We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+11.39%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$7.66B
AUM Growth
+$952M
Cap. Flow
+$371M
Cap. Flow %
4.84%
Top 10 Hldgs %
9.93%
Holding
1,511
New
90
Increased
296
Reduced
294
Closed
110

Top Sells

Rank Stock Value
1
TSN icon
Tyson Foods
TSN
+$63.7M
2
JPM icon
JPMorgan Chase
JPM
+$46.6M
3
ATVI
Activision Blizzard
ATVI
+$40.5M
4
AWK icon
American Water Works
AWK
+$37.3M
5
SYY icon
Sysco
SYY
+$36.7M

Sector Composition

Rank Sector Weight
1 Financials 23.67%
2 Industrials 15.1%
3 Technology 11.49%
4 Consumer Discretionary 9.68%
5 Healthcare 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRD icon
1076
Friedman Industries
FRD
$240M
$524K 0.01%
78,700
SPNE
1077
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$520K 0.01%
65,800
+43,600
+196% +$368K
RGNX icon
1078
Regenxbio
RGNX
$620M
$517K 0.01%
27,852
-37,000
-57% -$707K
WWW icon
1079
Wolverine World Wide
WWW
$1.61B
$516K 0.01%
23,500
+1,200
+5% +$27.2K
MOH icon
1080
Molina Healthcare
MOH
$10.2B
$515K 0.01%
9,500
CALA
1081
DELISTED
Calithera Biosciences, Inc
CALA
$514K 0.01%
7,905
+12
+0.2% +$750
CMPR icon
1082
Cimpress
CMPR
$2.39B
$513K 0.01%
5,600
NHI icon
1083
National Health Investors
NHI
$3.72B
$512K 0.01%
+6,900
New +$507K
SES
1084
DELISTED
Synthesis Energy Systems Inc.
SES
$511K 0.01%
7,989
NTIP icon
1085
Network-1 Technologies
NTIP
$37M
$510K 0.01%
+150,000
New +$439K
CZR icon
1086
Caesars Entertainment
CZR
$6.06B
$509K 0.01%
+30,000
New +$420K
EVI icon
1087
EVI Industries
EVI
$181M
$508K 0.01%
35,000
DXLG icon
1088
Destination XL Group
DXLG
$31.2M
$506K 0.01%
119,100
-30,000
-20% -$128K
CBMG
1089
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$502K 0.01%
38,300
CBM
1090
DELISTED
Cambrex Corporation
CBM
$502K 0.01%
9,300
CVR icon
1091
Chicago Rivet & Machine Co
CVR
$10M
$499K 0.01%
12,000
CBIO
1092
Crescent Biopharma
CBIO
$537M
$499K 0.01%
818
-280
-26% -$175K
ECYT
1093
DELISTED
Endocyte, Inc. Common Stock
ECYT
$499K 0.01%
195,800
MFIN icon
1094
Medallion Financial
MFIN
$229M
$498K 0.01%
165,011
+58,700
+55% +$214K
PQ
1095
DELISTED
Petroquest Energy Inc Wd
PQ
$491K 0.01%
148,348
+50,000
+51% +$187K
GNCA
1096
DELISTED
Genocea Biosciences, Inc.
GNCA
$490K 0.01%
14,875
CVU icon
1097
CPI Aerostructures
CVU
$66.2M
$488K 0.01%
52,779
COHU icon
1098
Cohu
COHU
$2.26B
$487K 0.01%
35,000
ALOT icon
1099
AstroNova
ALOT
$225M
$485K 0.01%
34,000
GSL icon
1100
Global Ship Lease
GSL
$1.6B
$482K 0.01%
40,200

Similar funds

Bridgeway Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Bridgeway Capital Management held 1,511 positions worth $7.66B, up 14% from $6.71B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Bridgeway Capital Management deployed $371M of net new capital in Q4 2016, opening 90 new positions and adding to 296 existing holdings. Its largest new stake was LyondellBasell Industries: 655,800 shares worth $56.3M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 21% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Tyson Foods, an estimated $63.7M trimmed.

  • Bridgeway Capital Management's largest Q4 2016 buy was LyondellBasell Industries: 655,800 shares worth $56.3M.
  • Bridgeway Capital Management added most to Bank of America in Q4 2016, an estimated $62.8M increase.
  • Bridgeway Capital Management's biggest Q4 2016 reduction was Tyson Foods, cutting an estimated $63.7M.
  • Bridgeway Capital Management fully exited Activision Blizzard in Q4 2016, selling an estimated $40.5M.
  • Bridgeway Capital Management's ten largest holdings make up 9.9% of its $7.66B portfolio in Q4 2016.
  • Bridgeway Capital Management opened 90 new positions and closed 110 in Q4 2016.
  • Bridgeway Capital Management's portfolio value rose 14% quarter-over-quarter to $7.66B.

Based on Bridgeway Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.